{"schema_version":"secwatch.filing_event.v1","accession":"0000896622-22-000004","form_type":"8-K","ticker":"ATR","cik":"0000896622","company_name":"APTARGROUP, INC.","filed_at":"2022-02-17T23:59:59+00:00","discovered_at":"2026-05-14T18:04:10.237776+00:00","generated_at":"2026-06-27T07:16:14.753984+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"AptarGroup Q4 sales up 9% to $814M; adjusted EPS $0.93 (+3%); guides Q1 adj. EPS $0.92-$1.00","bullets":["Q4 reported EPS $0.85 (+8% YoY); adjusted EPS $0.93 (+3% YoY). Net income $58M.","Full-year 2021 sales record $3.23B (+10% reported, +7% core); adjusted EPS $3.88 (+4%).","Pharma segment core sales +8%; Beauty+Home +7%; Food+Beverage +28% in Q4.","Q1 2022 adjusted EPS guidance range $0.92-$1.00; based on EUR/USD 1.14 and tax rate 27-29%.","Dividend held at $0.38/share payable Feb 23; $200M remaining share repurchase authorization."],"urls":{"canonical":"https://secwatch.observer/filing/0000896622-22-000004","json":"https://secwatch.observer/filing/0000896622-22-000004.json","markdown":"https://secwatch.observer/filing/0000896622-22-000004.md","text":"https://secwatch.observer/filing/0000896622-22-000004.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/896622/000089662222000004/0000896622-22-000004-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/896622/000089662222000004/atr-20220217.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-27T07:16:14.753984+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}